Allergic Bronchopulmonary Aspergillosis and Hypersensitivity Pneumonitis

Middleton's Allergy: Principles and Practice: Eighth Edition

Volumn 1-2, Issue , 2014, Pages 1000-1013

  Douglass, Jo A ^a   Sandrini, Alessandra ^b   Holgate, Stephen T ^c   O'Hehir, Robyn E ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84924239050     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-08593-9.00062-0     Document Type: Chapter

References (78)

1. Hinson KFW, Moon AJ, Plummer NS Bronchopulmonary aspergillosis. Thorax 1952, 7:317-333.
2. Schwartz HJ, Greenberger PA The prevalence of allergic bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. J Lab Clin Med 1991, 117:138-142.
3. Agarwal R, Aggarwal AN, Gupta D, Jindal SK Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis 2009, 13:936-944.
4. Carneiro ACC, Lemos ACM, Arruda SM, Santana MAPS Prevalence of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis in the state of Bahia, Brazil. J Brasil Pneumol 2008, 34:900-906.
5. Jubin V, Ranque S, Stremler Le Bel N, Sarles J, Dubus JC Risk factors for Aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Pediatr Pulmonol 2010, 45:764-771.
6. Patterson K, Strek ME Allergic bronchopulmonary aspergillosis. Proc Am Thorac Soc 2010, 7:237-244.
7. Laufer P, Fink JN, Bruns WT, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. J Allergy Clin Immunol 1984, 73:44-48.
8. Tillie-Leblond I, Tonnel AB Allergic bron-chopulmonary aspergillosis. Allergy 2005, 60:1004-1013.
9. Amitani R, Kawanami R Interaction of Aspergillus with human respiratory mucosa: a study with an organ culture model. Med Mycol 2009, 47:S127-S131.
10. Kauffman HF, Tomee JF, van der Werf TS, de Monchy JG, Koeter GK Review of fungus-induced asthmatic reactions. Am J Respir Crit Care Med 1995, 151:2109-2115.
11. Buckland KF, O'Connor E, Murray LA, Hogaboam CM Toll-like receptor-2 modulates both innate and adaptive immune responses during chronic fungal asthma in mice. Inflamm Res 2008, 57:379-387.
12. Carvalho A, Pasqualotto AC, Pitzurra L, et al. Polymorphisms in Toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis 2008, 197:618-621.
13. Garcia G, Humbert M, Capel F, et al. Chemokine receptor expression on allergen-specific T cells in asthma and allergic bronchopulmonary aspergillosis. Allergy 2007, 62:170-177.
14. Moreira AP, Cavassani KA, Hullinger R, et al. Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore-induced allergic airway disease. J Allergy Clin Immunol 2010, 126:712-721.
15. Vaid M, Kaur S, Sambatakou H, et al. Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Clin Chem Lab Med 2007, 45:183-186.
16. Gautam P, Sundaram CS, Madan T, et al. Identification of novel allergens of Aspergillus fumigatus using immunoproteomics approach. Clin Exp Allergy 2007, 37:1239-1249.
17. Glaser AG, Kirsch AI, Zeller S, et al. Molecular and immunological characterization of Asp f 34, a novel major cell wall allergen of Aspergillus fumigatus. Allergy 2009, 64:1144-1151.
18. Singh B, Oellerich M, Kumar R, et al. Immuno-reactive molecules identified from the secreted proteome of Aspergillus fumigatus. J Proteome Res 2010, 9:5517-5529.
19. Miller PW, Hamosh A, Macek M, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet 1996, 59:45-51.
20. Koehm S, Slavin RG, Hutcheson PS, et al. HLA-DRB1 alleles control allergic bronchopulmonary aspergillosis-like pulmonary responses in humanized transgenic mice. J Allergy Clin Immunol 2007, 120:570-577.
21. Knutsen AP, Hutchinson PS, Albers GM, et al. Increased sensitivity to IL-4 in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Allergy 2004, 59:81-87.
22. Sambatakou H, Pravica V, Hutchinson IV, Denning DW Cytokine profiling of pulmonary aspergillosis. Int J Immunogenet 2006, 33:297-302.
23. Brouard J, Knauer N, Boelle P-Y, et al. Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis. J Infect Dis 2005, 191:1988-1991.
24. Agarwal R Allergic bronchopulmonary aspergillosis. Chest 2009, 135:805-826.
25. Rosenberg M, Patterson R, Mintzer R, et al. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977, 86:405-414.
26. Patterson R, Greenberger PA, Halwig JM Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 1986, 146:916-918.
27. Jacoby B, Longbottom JL, Pepys J The uptake of Aspergillus fumigatus protein by serum IgG antibody from patients with pulmonary aspergillosis. Clin Allergy 1977, 7:117-125.
28. Greenberger PA, Patterson R Allergic bron-chopulmonary aspergillosis: model of bron-chopulmonary disease with defined serologic, radiologic, pathologic and clinical findings from asthma to fatal destructive lung disease. Chest 1987, 91:165S-171S.
29. Greenberger PA Diagnosis and management of allergic bronchopulmonary aspergillosis. Allergy Proc 1994, 15:335-339.
30. O'Driscoll BR, Powell G, Chew F, et al. Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma. Clin Exp Allergy 2009, 39:1677-1683.
31. Fairs A, Agbetile J, Hargadon B, et al. IgE sensitization to Aspergillus fumigatus is asso-ciated with reduced lung function in asthma. Am J Respir Crit Care Med 2010, 182:1362-1368.
32. Stevens DA, Moss RB, Kurup VP, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: state of the art. Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003, 37(Suppl 3):S225-S264.
33. Delhaes L, Frealle E, Pinel C Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: state of the art and further challenges. Med Mycol 2010, 48(Suppl 1):S77-S87.
34. Ghosh T, Dey A, Biswas D, et al. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis among asthma patients in eastern India. J Indian Med Assoc 2010, 108:863-865.
35. Casaulta C, Fluckiger S, Crameri R, Blaser K, Schoeni MH Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA. Pediatr Allergy Immunol 2005, 16:217-225.
36. McCarthy DS, Pepys J Allergic broncho-pulmonary aspergillosis: clinical immunology. 2. Skin, nasal and bronchial tests. Clin Allergy 1971, 1:415-432.
37. Agarwal R, Gupta D, Aggarwal AN, et al. Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis. Respir Med 2010, 104:204-210.
38. Blot SI, Taccone FS, van den Abeele AM, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. The AspICU Study Investigators. Am J Respir Crit Care Med 2012, 186:56-64.
39. Panchal N, Bhagat R, Pant C, Shah A Allergic bronchopulmonary aspergillosis: the spectrum of computed tomography appearances. Respir Med 1997, 91:213-219.
40. Menzies D, Holmes L, McCumesky G, Prys-Picard C, Niven R Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy 2011, 66:679-685.
41. Agarwal R, Khan A, Gupta D, et al. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS One 2010, 5.
42. Kumar R Mild, moderate, and severe forms of allergic bronchopulmonary aspergillosis: a clinical and serologic evaluation. Chest 2003, 124:890-892.
43. Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest 2006, 130:442-448.
44. Vlahakis NE, Aksamit TR Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc 2001, 76:930-938.
45. Limper AH, Knox KS, Sarosi GA, et al. An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med 2011, 183:96-128.
46. Cohen-Cymberknoh M, Blau H, Shoseyov D, et al. Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis. J Cystic Fibrosis 2009, 8:253-257.
47. Thomson JM, Wesley A, Byrnes CA, Nixon GM Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis. Pediatr Pulmonol 2006, 41:164-170.
48. Agarwal R, Khan A, Aggarwal AN, et al. Role of inhaled corticosteroids in the management of serological allergic bronchopulmonary aspergillosis (ABPA). Intern Med 2011, 50:855-860.
49. Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000, 342:756-762.
50. Wark PAB, Hensley MJ, Saltos N, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003, 111:952-957.
51. Glackin L, Leen G, Elnazir B, Greally P Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Irish Med J 2009, 102:29.
52. Tillie-Leblond I, Germaud P, Leroyer C, et al. Allergic bronchopulmonary aspergillosis and omalizumab. Allergy 2011, 66:1254-1256.
53. Zirbes JM, Milla CE Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol 2008, 43:607-610.
54. Campbell JM Acute symptoms following work with hay. BMJ 1932, 2:1143-1144.
55. Reed CE, Barbee RA Pigeon-breeder's lung: a newly observed insterstitial pulmonary disease. JAMA 1965, 193:261-265.
56. Hendrick DJ, Faux JA, Marshall R Budgerigar-fancier's lung: the commonest variety of allergic alveolitis in Britain. BMJ 1978, 2:81-84.
57. Yoshizawa Y, Ohtsuka M, Noguchi K, et al. Hypersensitivity pneumonitis induced by toluene diisocyanate: sequelae of continuous exposure. Ann Intern Med 1989, 110:31-34.
58. Ameille J, Brechot JM, Brochard P, Capron F, Dore MF Occupational hypersensitivity pneumonitis in a smelter exposed to zinc fumes. Chest 1992, 101:862-863.
59. Kunimasa K, Arita M, Tachibana H, et al. Chemical pneumonitis and acute lung injury caused by inhalation of nickel fumes. Intern Med 2011, 50:2035-2038.
60. Cormier Y, Schuyler M Hypersensitivity pneumonitis and organic dust toxic syndromes 2006, Marcel Dekker, New York.
61. Cormier Y, Belanger J, Durand P Factors influencing the development of serum precipitins to farmer's lung antigen in Quebec dairy farmers. Thorax 1985, 40:138-142.
62. Coultas DB, Zumwalt RE, Black WC, Sobonya RE The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994, 150:967-972.
63. Richerson HB, Bernstein IL, Fink JN, et al. Guidelines for the clinical evaluation of hypersensitivity pneumonitis. Report of the Sub-committee on Hypersensitivity Pneumonitis. J Allergy Clin Immunol 1989, 84:839-844.
64. Xaubet A, Ancochea J, Morell F, et al. Report on the incidence of interstitial lung diseases in Spain. Sarcoidosis Vasc Diffuse Lung Dis 2004, 21:64-70.
65. Terho EO, Husman K, Vohlonen I Prevalence and incidence of chronic bronchitis and farmer's lung with respect to age, sex, atopy and smoking. Eur J Respir Dis Suppl 1987, 152:19-28.
66. Hanak V, Kalra S, Aksamit TR, et al. Hot tub lung: presenting features and clinical course of 21 patients. Respir Med 2006, 100:610-615.
67. Tillie-Leblond I, Grenouillet F, Reboux G, et al. Hypersensitivity pneumonitis and metalworking fluids contaminated by mycobacteria. Eur Respir J 2011, 37:640-647.
68. Chan AL, Juarez MM, Leslie KO, Ismail HA, Albertson TE Bird fancier's lung: a state-of-the-art review. Clin Rev Allergy Immunol 2012, 43:69-83.
69. Barrera L, Mendoza F, Zuniga J, et al. Functional diversity of T-cell subpopulations in subacute and chronic hypersensitivity pneumonitis. Am J Respir Crit Care Med 2008, 177:44-55.
70. Girard M, Israel-Assayag E, Cormier Y Impaired function of regulatory T-cells in hypersensitivity pneumonitis. Eur Respir J 2011, 37:632-639.
71. Blanchet MR, Bennett JL, Gold MJ, et al. CD34 is required for dendritic cell trafficking and pathology in murine hypersensitivity pneumonitis. Am J Respir Crit Care Med 2011, 184:687-698.
72. Hodgson MJ, Parkinson DK, Karpf M Chest x-rays in hypersensitivity pneumonitis: a metaanalysis of secular trend. Am J Ind Med 1989, 16:45-53.
73. Lacasse Y, Selman M, Costabel U, et al. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 2003, 168:952-958.
74. Ando M, Konishi K, Yoneda R, Tamura M Difference in the phenotypes of bronchoalveolar lavage lymphocytes in patients with summer-type hypersensitivity pneumonitis, farmer's lung, ventilation pneumonitis, and bird fancier's lung: report of a nationwide epidemiologic study in Japan. J Allergy Clin Immunol 1991, 87:1002-1009.
75. Dickie HA, Rankin JR An acute granulomatous interstitial pneumonitis occurring in agricultural workers. JAMA 1958, 167:1069-1076.
76. Takemura T, Akashi T, Ohtani Y, Inase N, Yoshizawa Y Pathology of hypersensitivity pneumonitis. Curr Opin Pulm Med 2008, 14:440-454.
77. Akashi T, Takemura T, Ando N, et al. Histopathologic analysis of sixteen autopsy cases of chronic hypersensitivity pneumonitis and comparison with idiopathic pulmonary fibrosis/usual interstitial pneumonia. Am J Clin Pathol 2009, 131:405-415.
78. Ohtani Y, Saiki S, Kitaichi M, et al. Chronic bird fancier's lung: histopathological and clinical correlation-an application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 2005, 60:665-671.